TL-532, a novel specific Toll-like receptor 3 agonist rationally designed for targeting cancers: discovery process and biological characterization

Sylvain Thierry; Sarah Maadadi; Aurore Berton; Laura Dimier; Clémence Perret; Nelly Vey; Saïd Ourfali; Mathilde Saccas; Solène Caron; Mathilde Boucard-Jourdin; Marc Colombel; Bettina Werle; Marc Bonnin (2023). TL-532, a novel specific Toll-like receptor 3 agonist rationally designed for targeting cancers: discovery process and biological characterization. Microbial Cell, 10(6), 117-132. https://doi.org/10.15698/mic2023.06.797